Journal article

Choosing and sequencing novel drugs in CLL: dealing with an embarrassment of riches?

CS Tam, JF Seymour

Annals of Oncology | OXFORD UNIV PRESS | Published : 2017

DOI: 10.1093/annonc/mdx103

Keywords

Fludarabine
Oncology
Idelalisib
Initial Therapy
Venetoclax
Science & Technology
Chronic Lymphocytic-Leukemia
Regimen
Life Sciences & Biomedicine
Cyclophosphamide
Rituximab
Ibrutinib